cuprins - Gr.T. Popa

REZUMAT – TEZA DE DOCTORAT
114. Goutebroze L., Brault E., Muchardt C., Camonis J., Thomas G., Cloning and
characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and
naturally occurring mutant NF2 proteins. Mol Cell Biol 2000;20:1699–1712.
115. Gutmann D.H., Donahoe J., Perry A., Lemke N., Gorse K., Kittiniyom K. et al., Loss of DAL-
1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of
meningiomas. Hum Mol Genet 2000;9:1495–1500.
116. Kirsch M., Zhu J.J., Black P.M., Analysis of the BRCA1 and BRCA2 genes in sporadic
meningiomas. Genes Chromosomes Cancer 1997;20:53–9.
117. Cho H., Ha S.Y., Park S.H., Park K., Chae Y.S., Role of p53 gene mutation in tumor
aggressiveness of intracranial meningiomas. J Korean Med Sci 1999;14:199–205.
118. Santarius T., Kirsch M., Nikas D.C., Imitoal J., Black P.M., Molecular analysis of alteration
of the p18INK4c gene in human meningiomas. Neuropathol Appl Neurobiol 2000;26:67–75.
119. Mueller P., Henn W., Niedermayer I., Ketter R., Feiden W., Steudel W.I. et al., Deletion of
chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas.
Clin Cancer Res 1999;5:3569–77.
120. Scoles D.R., Huynh D.P., Chen M.S., Burke S.P., Gutmann D.H., Pulst S-M., The
neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth-factor regulated
tyrosine kinase substrate. Hum Mol Genet 2000;9:1567–74.
121. Cooper C., Jones H.G., Weller R.O. et al., Production of prostaglandins and thromoboxane
by isolated cells from intracranial tumors. J Neurol Neurosurg Psychiatry 1984;47:579–84.
122. Scanlon K.J., Kashani-Sabet M., Ribozymes as therapeutic agents: are we getting closer? J
Natl Cancer Inst 1998;90:558–9.
123. Levitzki A., Protein tyrosine kinase inhibitors as novel therapeutic agents. Pharmacol Ther
1999;82:231–9.
124. Sebolt-Leopold J.S., Dudley D.T., Herrera R. et al., Blockade of the MAP kinase pathway
suppresses growth of colon tumors in vivo. Nat Med 1999;5:810–16.
125. Smigel K., Arthritis drug approved for polyp prevention blazes trail for other prevention
trials. J Natl Cancer Inst 2000;92:297–9.
126. Park Y.S., Lee J.H., Harwalkar J.A., Bondar J., Safayhi H., Golubic M., Acetyl-11B-
Boswellic Acid (AKBA) is cytotoxic for meningioma cells and inhibits phosphorylation of the
extracellular-signal regulated kinase 1 and 2. In: Honn KV, Nigam S, Marnett IJ, Dennis E,
editors. Proceedings of the 6th International Conference on Eicosanoids and Other Bioactive
Lipids in Cancer, Inflammation and Related Diseases. New York: Plenum Publishing, 2000.
127. Adam D., Subiecte de neurochirurgie, Ed. Medexim, Bucureşti, 1992.
128. Aldea H. si col., Curs de Neurochirurgie, 2003
129. Aldea H., Ianovici N., Turliuc Dana, Curs de neurochirurgie, Ed. Dosoftei, Iaşi, 1999
130. Greenberg M., Handbook of Neurosurgery. 5th Edition. New York: Thieme; 2001
131. Sinelnikov R.D., Atlas of human anatomy, vol. III – The science of the nervous system,
sense organs and endocrine glands, Mir Publishers, Moscova, 1990
132. McDermott M.W., Wilson C.B:, Meningiomas, in Youmans JR (ed): Neurological
Surgery, ed 4. Philadelphia: WB Saunders, 1996, pp 2782 2825
133. Mehta N., Bhagwati S., Parulekar G., Meningiomas in children: A study of 18 cases. J Pediatr
Neurosci 2009;4:61-5
134. Rahmah N.N., Brotoarianto H.K., Andar E., Kusnarto G., Muttaqin Z., Hongo K., Dural
plasmacytoma mimicking meningioma in a young patient with multiple myeloma, Biomed Imaging Interv
J 2009; 5(2):e5